Is IO Biotech Inc (IOBT) overvalued? · $98.2M cap
IO Biotech Inc (IOBT) is a biotechnology company listed on US.
This page asks whether IO Biotech Inc (IOBT) looks expensive on cached numbers — not a short thesis.
No cached income statement for IOBT, so there is no earnings base to call rich or cheap.
IOBT currently screens at market cap $98.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next IOBT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the IOBT stock page for the full model, not this heading.
Not investment advice.